154 related articles for article (PubMed ID: 30029053)
1. Competing mortality risks among women aged 50-79 years when diagnosed with invasive breast cancer, Queensland, 1997-2012.
Dasgupta P; Aitken JF; Pyke C; Baade PD
Breast; 2018 Oct; 41():113-119. PubMed ID: 30029053
[TBL] [Abstract][Full Text] [Related]
2. Partner status and survival after cancer: A competing risks analysis.
Dasgupta P; Turrell G; Aitken JF; Baade PD
Cancer Epidemiol; 2016 Apr; 41():16-23. PubMed ID: 26775082
[TBL] [Abstract][Full Text] [Related]
3. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
4. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.
Abdel-Qadir H; Austin PC; Lee DS; Amir E; Tu JV; Thavendiranathan P; Fung K; Anderson GM
JAMA Cardiol; 2017 Jan; 2(1):88-93. PubMed ID: 27732702
[TBL] [Abstract][Full Text] [Related]
5. Temporal trends in net and crude probability of death from cancer and other causes in the Australian population, 1984-2013.
Dasgupta P; Cramb S; Kou K; Yu XQ; Baade PD
Cancer Epidemiol; 2019 Oct; 62():101568. PubMed ID: 31330423
[TBL] [Abstract][Full Text] [Related]
6. An analysis of competing mortality risks among colorectal cancer survivors in Queensland, 1996-2009.
Dasgupta P; Youlden DR; Baade PD
Cancer Causes Control; 2013 May; 24(5):897-909. PubMed ID: 23408244
[TBL] [Abstract][Full Text] [Related]
7. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.
He VY; Condon JR; Baade PD; Zhang X; Zhao Y
Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862
[TBL] [Abstract][Full Text] [Related]
8. Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona.
Ameijide A; Clèries R; Carulla M; Buxó M; Marcos-Gragera R; Martínez JM; Vilardell ML; Vilardell M; Espinàs JA; Borràs JM; Izquierdo Á; Galceran J
Clin Transl Oncol; 2019 Aug; 21(8):1014-1025. PubMed ID: 30607790
[TBL] [Abstract][Full Text] [Related]
9. Competing Risk of Death in Elderly Patients with Newly Diagnosed Stage I Breast Cancer.
Wasif N; Neville M; Gray R; Cronin P; Pockaj BA
J Am Coll Surg; 2019 Jul; 229(1):30-36.e1. PubMed ID: 30930100
[TBL] [Abstract][Full Text] [Related]
10. Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data.
Wright CM; Nowak AK; Halkett G; Moorin RE
BMC Public Health; 2020 Jun; 20(1):1002. PubMed ID: 32586298
[TBL] [Abstract][Full Text] [Related]
11. Effect of age at diagnosis of breast cancer on the patterns and risk of mortality from all causes: a population-based study in Australia.
Beadle GF; McCarthy NJ; Baade PD
Asia Pac J Clin Oncol; 2013 Jun; 9(2):129-38. PubMed ID: 22898239
[TBL] [Abstract][Full Text] [Related]
12. Competing risks to breast cancer mortality in Catalonia.
Vilaprinyo E; Gispert R; Martínez-Alonso M; Carles M; Pla R; Espinàs JA; Rué M
BMC Cancer; 2008 Nov; 8():331. PubMed ID: 19014473
[TBL] [Abstract][Full Text] [Related]
13. Crude probability of death for cancer patients by spread of disease in New South Wales, Australia 1985 to 2014.
Yu XQ; Dasgupta P; Kahn C; Kou K; Cramb S; Baade P
Cancer Med; 2021 Jun; 10(11):3524-3532. PubMed ID: 33960140
[TBL] [Abstract][Full Text] [Related]
14. Quantifying differences in breast cancer survival between England and Norway.
Lambert PC; Holmberg L; Sandin F; Bray F; Linklater KM; Purushotham A; Robinson D; Møller H
Cancer Epidemiol; 2011 Dec; 35(6):526-33. PubMed ID: 21606014
[TBL] [Abstract][Full Text] [Related]
15. Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk.
Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Hankinson SE; Marcantonio ER; Ngo LH
Breast Cancer Res Treat; 2016 Dec; 160(3):547-562. PubMed ID: 27770283
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Risk of Metastatic Recurrence for Female Breast Cancer Patients in the Presence of Competing Causes of Death.
Mariotto AB; Botta L; Bernasconi A; Zou Z; Gatta G; Capocaccia R
Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1683-1689. PubMed ID: 37707367
[TBL] [Abstract][Full Text] [Related]
17. Geographical differences in risk of advanced breast cancer: Limited evidence for reductions over time, Queensland, Australia 1997-2014.
Dasgupta P; Youl PH; Aitken JF; Turrell G; Baade P
Breast; 2017 Dec; 36():60-66. PubMed ID: 28985515
[TBL] [Abstract][Full Text] [Related]
18. Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk.
Bach AC; Lo KS; Pathirana T; Glasziou PP; Barratt AL; Jones MA; Bell KJ
Med J Aust; 2020 Jan; 212(1):17-22. PubMed ID: 31691294
[TBL] [Abstract][Full Text] [Related]
19. Incidence of invasive breast cancer in the presence of competing mortality: the Canadian National Breast Screening Study.
Taghipour S; Banjevic D; Fernandes J; Miller AB; Montgomery N; Harvey BJ; Jardine AK
Breast Cancer Res Treat; 2012 Jul; 134(2):839-51. PubMed ID: 22689090
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
